SP

Shouvik Pine

Active Director Director DIN 08800504
DIN 08800504 First appointment Jul 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Shouvik Pine

Data last updated:

Shouvik Pine is a Director at Stemcelline Private Limited (since 2020). The company operates in Healthcare. Stemcelline Private Limited reported revenue of ₹6.1 Lakh (FY 2024).

DIN 08800504
Primary Designation Director
Industry Healthcare
First Appointment 19 Jul 2020
Oldest Company Age 6 yrs
Largest company Stemcelline Private Limited · ₹6.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stemcelline Private Limited U85100HR2020PTC087653
Director19 Jul 20202020₹6.1 Lakh (FY 2024)Active

Board colleagues of Shouvik Pine

NameDINCompanyDesignation
Arun Bikas Pine08800503Stemcelline Private LimitedDirector

Directorship timeline

Open interactive timeline →
Stemcelline Private Limited
Premium access

Shareholding and investment profile for Shouvik Pine

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shouvik Pine

Shouvik Pine currently holds 1 directorship: Stemcelline Private Limited (Director, since 19 Jul 2020, revenue ₹6.1 Lakh (FY 2024)).

Shouvik Pine was first appointed on 19 Jul 2020 as Director at Stemcelline Private Limited.

The current boards of Shouvik Pine's companies include Arun Bikas Pine (Stemcelline Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available